拜耳（BAYN -1.01%下跌）表示，计划投资22亿美元在俄亥俄州建设新的制造基地，用于其制药业务，成为最新一家在美国投资的欧洲药企。
Bayer BAYN -1.01%decrease; down pointing triangle said it plans to spend $2.2 billion to build a new manufacturing site in Ohio for its pharmaceutical business, becoming the latest European drugmaker to invest in the U.S.
这家德国农业和制药集团周五表示，其位于新奥尔巴尼的新基地将创造约600个就业岗位，计划于2031年开放首个专注于原料药制造的模块，随后于2034年开放第二个成品药模块。
The German agricultural and pharmaceutical group said Friday that its new site in New Albany will create around 600 jobs, with plans to open a first module dedicated to drug substance manufacturing in 2031, followed by a second module for finished products in 2034.